Anton Moritz. Department of Cardiothoracic Surgery University of Frankfurt
|
|
- Shawn Jacobs
- 5 years ago
- Views:
Transcription
1 Anton Moritz Department of Cardiothoracic Surgery University of Frankfurt
2 Long Term Survival after Valve Replacement
3 Autograft Long term survival after Ross or AVR mechanical compared to normal life expectancy Mechanical protheses Martin Andreas et al. Eur J Cardiothorac Surg 2014;46: The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
4
5 Scharfschwerdt M Ann Th Surg 2007
6 Re OP s autograft n= 100 Mean follow up period 13 a 4 re OP s in 1147 ptyrs (0.35%/yr) Re OP s RVOT 7 patients intervention on homograft (7,7%) 0.8%/yr dgthg 2011, Stuttgart Seebacher et al.
7 RVOT after Ross RVOT after Congenital Surgery Brown JW Ann Th Surg 2008 Homografts show good durability but develop gradients. Bioprosthetic replacement an option? 45% 19% Survival free of reop n=1065 Dearani JA, Ann Th Surg 2003
8 Proximal RVOT strictures developed Perikardsleeve solves the proximal but aggravates the distal problem
9 Freedom from neopulmonary valve failure after 5 years: 97% in homografts versus 73% in bioprosthesis logrank test: p< Hazard Ratio: 6.1 (95% CI ) Homograft Bioprosthesis Time (years) Number at risk Group: Homograft Group: Bioprosthesis Incidence rate: 1:80 pat. year in homografts versus 1:14 pat.year in xenografts. p<0, Text durch klicken bearbeiten 9
10 4/193
11 Aorta conjoined leaflet non coronary leaflet left ventricle
12
13 Durchmesser Aorta ascendens mm Gesamtkollektiv Bikuspid Trikuspid Insuffizienz Kombiniert Stenose Aortenraffung Entlassungsuntersuchung Letzte Follow up Untersuchung
14 Das
15
16
17 Autografts at Reoperation
18 Long Term Complications 18 Reoperations on AG, but only 6 valve replacements 9 embolic events related to a-fib (0,54% / pt yr) 9 events of endocarditis (0,54% / pt yr) No ACH related bleeding or valve thrombosis
19 Valve-related complications Event Mechanical valve (n = 173) Ross procedure (n = 159) P-value Stroke 5.8% (1.02%/pt yr) 0.6% (0.06%) <0.01 TIA 1.7% (0.25%) 0% (0%) 0.07 Valve thrombosis 0.6% (0.08%) /1,35% 0% (0%) / 0.06% 0.30 Endocarditis 5.2% (0.76%) 3.8% (0.38%) 0.32 Bleeding 10.4% (1.95%) 0.6% (0.06%) <0.01 Reintervention 5.8% (0.85%) 12.6% (1.27%) 0.05
20 Long Term Survival Sievers H. Ross vs mech randomisiert Mortality 10 vs 40% Bleeding 0 vs 25% Reoperation 15 vs 5% Miskovic et al EACTS 2014 Seebacher Vienna 13 a
21 Summary When respecting certain technical principles the Ross procedure provides excellent and stable hemodynamics in the long term. Valve related complications are reduced to reoperations and which are due to conceptual problems in majority. Degenerations are rare AG provides a durable biologic valve. RVOT replacement is a possible long term problem but might be cured percutaneousely in the future. Normal long term survival appears to be the major asset of this technically demanding procedure. Projekt / Datum / Name
22 Reop oder AI III Böhm JO. AnnThSurg 2009 Reoperationen
23 interventricular septum in cm Regression of left ventricular hypertrophy 2.5 Mean gradient in mmhg 2 Interventricular Septum implant 1 year 10 years
24 Mortality Long term n=2 (10%) n=8 (40%) Valve related n= 1 n= 5 bleeding n=0 n=5 (25%) thromboembolism n=1 n=1 Reoperation n=3 (15%) n=1 (5%)
25 Wrap N= ASC.events yrs to event FU no 33 Effect 9 of Wrap ,3 Vicryl_Mesh ,6 6.9 Vypro_Mesh David Total Dilatation or Reoperation
26 Statistik nur für Bioprothesen PK_Event = entweder Reintervention oder PS>50mmHg oder PI>II Häufigkeit Prozent direkte Naht nein 43 74,1 ja(reop oder sign Dysf) 15 25,9 Gesamtsumme ,0 Plus Pach/Sleeve nein 34 89,5 ja(reop oder sign Dysf) 4 10,5 Gesamtsumme ,0 Reintervention an der Bioprothese in Pulmonalklappenposition Häufigkeit Prozent direkte Naht nein 45 77,6 ja 13 22,4 Gesamtsumme ,0 Plus Pach/Sleeve nein 36 94,7 ja 2 5,3 Gesamtsumme ,0
27 100 Survival Logrank test : P = 0,15 Location Wien Frankfurt Time Number at risk Group: Wien Group: Frankfurt
28 Projekt / Datum / Name RVOT Reinterventions
29 Projekt / Datum / Name Reoperations Aorta
30 All Reinterventions 60% event free at 18 years Projekt / Datum / Name
31 Optimized Reinterventions 89% event free at 18 yrs With current knowledge avoidable reinterventions excluded: RVOT strictures, pseudoaneurysms and aortic dilatations Projekt / Datum / Name
32 Outcome Reintervention Total Homograft Xenograft Signific. (n=205) (n=113) (n= 92) Time to redo (y) 6.4 years 9.6 years 4.5 years p=0.003 (± SD) (± 4.8) (± 4.8) (±3.9) Reintervention n.s. Reoperation Perc. Procedure p=0.005 Balloon dilatation in 10, Melody implantation in 4 Re-reintervention n.s. Balloon dilatation in 2, Melody implantation in 4 Main Finding Stricture p=0.03 Degeneration Endocarditis Text durch klicken bearbeiten 32
33
34 Event at the neopulmonary valve in Bioprosthesis Reintervention or PS (>50mmHG) without pericardial sleeve Event no Event plus pericardial sleeve % 20% 40% 60% 80% 100% Text durch klicken bearbeiten 34
35
36 100 Reoperation of the Pulmonary Autograft Logrank test : P = 0,12 Location Wien Frankfurt Time Number at risk Group: Wien Group: Frankfurt
The Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More information-The Living Aortic Valve- Repair or Else? Ismail El-Hamamsy, MD PhD
-The Living Aortic Valve- Repair or Else? Ismail El-Hamamsy, MD PhD Associate Professor Director, Aortic Surgery Division of Cardiac Surgery Montreal Heart Institute Université de Montreal PhD Thesis Imperial
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationRV- PA Surgical Valve Choices in Adults longevity and risks
RV- PA Surgical Valve Choices in Adults longevity and risks ACHD, Queenstown, 2017 Adult Congenital Heart Surgery 1991 8/3/2017 Total = 751 Patients 200 180 160 140 120 100 80 60 40 20 0 Primary Diagnosis
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement Christian Kreutzer MD Hospital Nacional Alejandro Posadas Hospital Universitario Austral (No disclosures) Scope of the problem. CHD with PS or PA require a RVOT procedure. Tetralogy
More informationIndications and Late Results of Aortic Valve Repair
Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationThe pulmonary valve is the most common heart valve
Biologic versus Mechanical Valve Replacement of the Pulmonary Valve After Multiple Reconstructions of the RVOT Tract S. Adil Husain, MD, and John Brown, MD Indiana University School of Medicine, Department
More informationExcellence in heart and lung care. Royal Brompton Hospital, Sydney Street, London SW3 6NP
The Surgical Management of the Bicuspid Aortic Valve in Children Professor D.F Shore Royal Brompton & Harefield NHS Trust Excellence in heart and lung care Royal Brompton Hospital, Sydney Street, London
More informationNative valve, Conduit stenosis or leakage? How can the interventionalist help?
Complications in Congenital Heart Diseases -with a little help of our friends Native valve, Conduit stenosis or leakage? How can the interventionalist help? P. Ewert German Heart Center Munich Lausanne
More informationTAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology
TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for
More informationClinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationCase. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)
Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography
More informationA FUTURE WITHOUT RE-OPERATIONS?
A FUTURE WITHOUT RE-OPERATIONS? New horizons in pulmonary heart valve therapy January 29, 2018 Prof. Dr. Gerardus Bennink Chief and head of pediatric cardio-thoracic congenital surgery Heart Center of
More informationMechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute
Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Assistant Professor, Georgetown School of Medicine
More informationEdwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?
Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval? Update from PARTNER EU and SOURCE Registries T. Lefèvre Disclosure Statement Cardiologist Interventional cardiologist 1 st PABV in
More informationSurgical options for tetralogy of Fallot
Surgical options for tetralogy of Fallot Serban Stoica FRCS(CTh) MD ACHD study day, 19 September 2017 Anatomy Physiology Children Adults Complications Follow up Anatomy Etienne Fallot (1850-1911) VSD Overriding
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationReconstruction of the Aortic Valve and Root A Practical approach Why and when to repair the aortic valve. Diana Aicher. September 16 th - 18 th 2015
Reconstruction of the Aortic Valve and Root A Practical approach Why and when to repair the aortic valve Diana Aicher September 16 th - 18 th 2015 Why repair the aortic valve? Aortic Valve Replacement
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationThe Role Of Decellularized Valve Prostheses In The Young Patient
The Role Of Decellularized Valve Prostheses In The Young Patient Francisco Diniz Affonso da Costa Human Tissue Bank PUCPR - Brazil Disclosures Ownership and patent license of the SDS decellularization
More informationSevere aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner
Severe aortic stenosis should be operated before symptom onset CONTRA Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center Dept. of Cardiology
More informationCardiac Surgery A Resource of Experimental Design
Cardiac Surgery A Resource of Experimental Design Complete Transposition: a. Atrial switch the chronically systemic right ventricle b. Arterial switch the suddenly systemic left ventricle Fontan operation
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationTranscatheter Pulmonary Valve Replacement Update on progress and outcomes
Transcatheter Pulmonary Valve Replacement Update on progress and outcomes Barry Love, MD Director, Congenital Cardiac Catheterization Laboratory Mount Sinai Medical Center New York, New York Transcatheter
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationEarly and One-year Outcomes of Aortic Root Surgery in Marfan Syndrome Patients
Early and One-year Outcomes of Aortic Root Surgery in Marfan Syndrome Patients A Prospective, Multi-Center, Comparative Study Joseph S. Coselli, Irina V. Volguina, Scott A. LeMaire, Thoralf M. Sundt, Elizabeth
More informationLong-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension?
Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension? Y d Udekem, J Siddiqui, C Seaman, I Konstantinov, J Galati, M Cheung, C Brizard Royal
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationTetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve
Tetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve Alexandra A Frogoudaki Adult Congenital Heart Clinic Second Cardiology Department ATTIKON University Hospital No
More informationFocused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.
ACC/AH HA 2006 Guidel nic severe AI (Fig. 4). ned by age, ay also be helpful nd echo. For AI, ollow up may be or MRI rather than mension; SD, end lines for Manag gement of Patie Upd ents With Valvul date
More informationStentless Xenografts and Homografts for Right Ventricular Outflow Tract Reconstruction During the Ross Operation
Stentless Xenografts and Homografts for Right Ventricular Outflow Tract Reconstruction During the Ross Operation Franz X. Schmid, MD, Andreas Keyser, MD, Christoph Wiesenack, MD, Stefan Holmer, MD, and
More informationLate failure of transcatheter heart valves: An open question
Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement
More informationInterventional procedures guidance Published: 26 July 2017 nice.org.uk/guidance/ipg586
Transcatheter aortic valve implantation for aortic stenosis Interventional procedures guidance Published: 26 July 17 nice.org.uk/guidance/ipg586 Your responsibility This guidance represents the view of
More informationProsthetic valve dysfunction: stenosis or regurgitation
Prosthetic valve dysfunction: stenosis or regurgitation Jean G. Dumesnil MD, FRCP(C), FACC, FASE(Hon) Quebec Heart and Lung Institute, Québec, Québec No disclosures Possible Causes of High Gradients in
More informationSurgical Repairs for LVOT Obstructive Lesions. John J. Lamberti MD
Surgical Repairs for LVOT Obstructive Lesions John J. Lamberti MD Surgical Repairs for LVOT Obstructive Lesions Presented by John J. Lamberti MD Faculty Disclosure Statement: I do not have any relevant
More informationDecellularization of Aortic Homografts: South American and European Current Experience
Department of Cardiac Surgery Instituto de Neurologia e Cardiologia de Curitiba (INC-Cardio) Decellularization of Aortic Homografts: South American and European Current Experience Francisco Diniz Affonso
More informationI will not discuss off label use or investigational use in my presentation.
I will not discuss off label use or investigational use in my presentation. Surgical valves Design and Durability Testing Potential Concerns Real Practice 1952-1962 1963-1966 1967-1969 1969-1977 1977-1984
More informationPercutaneous Aortic Valve Implantation. Core-Valve and Cribier-Edwards Update
Percutaneous Aortic Valve Implantation. Core-Valve and Cribier-Edwards Update T. Lefèvre Natural History of Aortic Stenosois 100 Latent period Survival (%) 80 60 40 20 Symptoms Average Age Death 0 40 50
More informationResults of Aortic Valve Preservation and Repair
Results of Aortic Valve Preservation and Repair Department of Cardiothoracic and Vascular Surgery Cliniques Universitaires St. Luc Brussels, Belgium Gebrine Elkhoury Institutional experience in AV preservation
More informationTranscatheter aortic valve implantation for aortic stenosis
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Transcatheter aortic valve implantation for aortic stenosis Aortic stenosis occurs when the aortic valve
More informationSpotlight on valvular heart disease guidelines. Prosthetic heart valves. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France
Spotlight on valvular heart disease guidelines. Prosthetic heart valves. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France Faculty disclosure First name - last name I disclose the following
More informationJoseph E. Bavaria, MD
EACTS Master Class on Aortic Valve Repair Joseph E. Bavaria, MD Director, Thoracic Aortic Surgery Program Roberts Measey Professor and Vice Chair of CV Surgery University of Pennsylvania Immediate-Past
More informationSotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.
CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director
More informationAlec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France
Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat
More informationKinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands
Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart
More informationSystematic review of aortic valve preservation and repair
Systematic Review Systematic review of aortic valve preservation and repair Richard Saczkowski 1, Tarek Malas 1, Laurent de Kerchove 2, Gebrine El Khoury 2, Munir Boodhwani 1 1 Division of Cardiac Surgery,
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationPPM: How to fit a big valve in a small heart
PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat
More informationCarpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience
SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member
More informationTissue vs Mechanical What s the Data??
Biological (Tissue) Valve in a 60 year old patient: Debate Tissue vs Mechanical What s the Data?? Joseph E. Bavaria, MD Immediate-Past President - Society of Thoracic Surgeons (STS) Brooke Roberts-William
More informationInter-surgeon variability in long-term outcomes after transatrial repair of tetralogy of Fallot: 25 years experience with 675 patients.
Inter-surgeon variability in long-term outcomes after transatrial repair of tetralogy of Fallot: 25 years experience with 675 patients. Y d'udekem, JC Galati, IE Konstantinov, MMH Cheung, CP Brizard Royal
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationSpotlight on Valvular Heart Disease Guidelines
Spotlight on Valvular Heart Disease Guidelines Aortic Valve Disease Raphael Rosenhek Department of Cardiology Medical University of Vienna Palermo, April 26 th 2018 1998 2002 2006 2007 2008 2012 2014 2017
More informationThe vast majority of patients, especially children, who
Technique of Mechanical Pulmonary Valve Replacement John M. Stulak, MD, and Joseph A. Dearani, MD The vast majority of patients, especially children, who require pulmonary valve replacement (PVR), obtain
More informationRole of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,
Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic, transplantation and Vascular Surgery Hannover Medical School, Germany
More informationCandice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada
PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary
More informationAscending Thoracic Aorta: Postsurgical CT Evaluation
Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martinez Jimenez, MD GOALS Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martínez MD smartinez-jimenez@saint-lukes.org Saint
More informationRe-do aortic valve replacement after previous homograft aortic root replacement
Re-do aortic valve replacement after previous homograft aortic root replacement Jullien Gaer, Toufan Bahrami, Fabio de Robertis, Ahmed Abdulsalam, John Pepper, NHS Foundation Trust, UK Professor Sir Magdi
More informationRVOTO adult and post-op
Right ventricular outflow tract obstruction in the adult: native and post-op Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center University of
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationHemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves
Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes
More informationCHAPTER VIII AUTOGRAFT OR ALLOGRAFT AORTIC ROOT REPLACEMENT?
CHAPTER VIII AUTOGRAFT OR ALLOGRAFT AORTIC ROOT REPLACEMENT? Autograft or allograft aortic root replacement? Johanna J.M. Takkenberg, MD, Lex A. van Herwerden, MD, PhD, Ewout W. Steyerberg, PhD, Marinus
More informationTreatment of congenital aortic valve disease: Neonatal surgical management. Pascal Vouhé - Sick Children Hospital, Paris
Treatment of congenital aortic valve disease: Neonatal surgical management Pascal Vouhé - Sick Children Hospital, Paris Challenges. valvar lesions. associated lesions. status of left ventricle Valvar lesions.
More informationLate results of aortic root repair & replacement. John Pepper Imperial College and Royal Brompton Hospital, London, UK.
Late results of aortic root repair & replacement John Pepper Imperial College and Royal Brompton Hospital, London, UK. REPLACEMENT OF ASCENDING AORTA AND ROOT Interposition graft Valve sparing VR + graft
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationShould We Reconsider using Anticoagulation for Biological Tissue Valves
Should We Reconsider using Anticoagulation for Biological Tissue Valves No Disclosures Disclosures Watching grass grow Complete with audio 1 hour 8 minutes 9884 views Subclinical Leaflet Thrombosis in
More informationCONGENITAL HEART DEFECTS IN ADULTS
CONGENITAL HEART DEFECTS IN ADULTS THE ROLE OF CATHETER INTERVENTIONS Mario Carminati CONGENITAL HEART DEFECTS IN ADULTS CHD in natural history CHD with post-surgical sequelae PULMONARY VALVE STENOSIS
More informationThe Journal of Thoracic and Cardiovascular Surgery
Accepted Manuscript The Ross procedure: time to re-evaluate the guidelines Martin Misfeld, MD PhD, Michael A. Borger, MD PhD PII: S0022-5223(18)31853-1 DOI: 10.1016/j.jtcvs.2018.07.014 Reference: YMTC
More informationExtension to medium and low risk patients? Friedrich Eckstein University Hospital Basel
TAVI CON Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel Extension to medium and low risk patients? In octogenerians already reality in most of the swiss clinics!?
More informationResults of the MELODY REGISTRY an international multicenter study of transcatheter pulmonary valve implantation
1 Results of the MELODY REGISTRY an international multicenter study of transcatheter pulmonary valve implantation Johannes Nordmeyer Marc Gewillig On behalf of the Melody investigators MELODY Registry
More informationTGA, VSD, and LVOTO. Cheul Lee, MD. Department of Thoracic and Cardiovascular Surgery Sejong General Hospital
Surgical Management of TGA, VSD, and LVOTO Cheul Lee, MD Department of Thoracic and Cardiovascular Surgery Sejong General Hospital TGA, VSD, and LVOTO Incidence : 0.7% of all CHD 20% of TGA with VSD 4%
More informationDECLARATION OF CONFLICT OF INTEREST. No disclosures
DECLARATION OF CONFLICT OF INTEREST No disclosures Congenital Aortic Valve Disease and Aortopathy: Recent Advances Sub- and Supravalvular Aortic Stenosis Westfälische Wilhelms-Universität Münster Helmut
More informationHani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.
Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility
More informationMandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium
Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc
More informationafter AV Canal Repair: When and How To Intervene
Left Atrioventricular Valve Regurgitation after AV Canal Repair: When and How To Intervene Thomas L Spray, M.D. Chief, Cardiothoracic Surgery Alice Langdon Warner Endowed Chair The Children s Hospital
More information25 different brand names >44 different models Sizes mm
Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationAppropriate Use of TAVR - now and in the future. A Surgeon s Perspective. Neil Moat Royal Brompton Hospital, London, UK
Appropriate Use of TAVR - now and in the future A Surgeon s Perspective Neil Moat Royal Brompton Hospital, London, UK Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner
More informationCase Studies in Complex Endocarditis
Case Studies in Complex Endocarditis Vera H. Rigolin, MD Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern Memorial Hospital
More informationAIIograft reconstruction of the right ventricular outflow tract
Eur J Cardio-thorac Surg (1996) 10:609-615 Springer-Verlag 1996 T. P. Willems A. J. J. C. Bogers A. H. Cromme-Dijkhuis E. W. Steyerberg L. A. van Herwerden R. B. Hokken J. Hess E. Bos Received: 17 October
More informationIndications and Outcomes of the Double Switch in cctga. David Barron Birmingham, UK
Indications and Outcomes of the Double Switch in cctga David Barron Birmingham, UK No Disclosures cctga: The Problem cctga does not fit into neat, clincially discrete sub-groups Atrial Situs Wide range
More informationPr Fadi FARHAT Service de Chirurgie Cardiovasculaire Adulte et Transplantation Hôpital Louis Pradel, Bron, FRANCE. NOM Intitulé du topo Date.
5 ème Journée Scientifique de la Réunion de Concertation Pluridisciplinaire sur l Endocardite Infectieuse du CHU de Lyon ENDOCARDITE AIGUE INFECTIEUSE Y A-T-IL UN SUBSTITUT VALVULAIRE IDEAL? Pr Fadi FARHAT
More informationWhen Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea
When Should We Consider TAVI Procedure in Korea (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea Aortic Stenosis in Korea Rapidly increasing valve disease in Korea Still low incidence
More informationCardiac catheterisation in AS
AORTIC STENOSIS MANAGEMENT OF VALVULAR AORTIC STENOSIS Dr Badri Paudel Third most common cardiovascular disease Most prevalent valvular heart disease in the world Commonest acquired valvular lesion with
More informationTRANSCATHETER REPLACEMENT OF THE PULMONARY VALVE (PPVI)
TRANSCATHETER REPLACEMENT OF THE PULMONARY VALVE (PPVI) BASIL D. THANOPOULOS MD, PhD Director Interventional Cardiology of CHD Euroclinic ATHENS - GREECE TRANSCATHETER REPLACEMENT OF THE PULMONARY VALVE
More informationFive-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial
Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
More informationIn 1980, Bex and associates 1 first introduced the initial
Technique of Aortic Translocation for the Management of Transposition of the Great Arteries with a Ventricular Septal Defect and Pulmonary Stenosis Victor O. Morell, MD, and Peter D. Wearden, MD, PhD In
More informationSurgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital
Surgical Management of TOF in Adults Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Tetralogy of Fallot (TOF) in Adults Most common cyanotic congenital heart
More informationHeart Center University of Cologne
A future without re-operations? New horizons in pulmonary heart valve therapy January 29, 2018 Prof. Dr. Gerardus Bennink Chief and head of pediatric cardio-thoracic congenital surgery Heart Center of
More informationSurgical Indications of Infective Endocarditis in Children
2016 Annual Spring Scientific Conference of the KSC April 15-16, 2016 Surgical Indications of Infective Endocarditis in Children Cheul Lee, MD Pediatric and Congenital Cardiac Surgery Seoul St. Mary s
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationAutologous Pulmonary Valve Replacement of the Diseased Aortic Valve
Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue
More informationAre Stented Bioprostheses Appropriate for Aortic Valve Replacement in Young Patients?
Are Stented Bioprostheses Appropriate for Aortic Valve Replacement in Young Patients? Frank A. Pigula MD Senior Associate Cardiac Surgery Children s Hospital Boston Associate Professor Surgery Harvard
More informationAortic root reconstructive surgery - new created technique for aortic stenosis
Aortic root reconstructive surgery - new created technique for aortic stenosis Reconstructive surgery of the aortic root Academician d-r Zan Mitrev, T.Anguseva, E.Stoicovski, E Idoski Special hospital
More informationWill we face a big problem with the aortic valve/root after ASO?
Will we face a big problem with the aortic valve/root after ASO? Laurence Iserin Unité médico-chirurgicale de Cardiologie Congénitale Adulte Hôpital Universitaire Européen Georges Pompidou APHP, Université
More informationTAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central
TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central Michigan University 1 Disclosure Chiesi Pharma- Consultant
More informationTAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?
TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular
More information